These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 24965756

  • 1. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.
    Siddiqui IA, Bharali DJ, Nihal M, Adhami VM, Khan N, Chamcheu JC, Khan MI, Shabana S, Mousa SA, Mukhtar H.
    Nanomedicine; 2014 Nov; 10(8):1619-26. PubMed ID: 24965756
    [Abstract] [Full Text] [Related]

  • 2. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.
    Khan N, Bharali DJ, Adhami VM, Siddiqui IA, Cui H, Shabana SM, Mousa SA, Mukhtar H.
    Carcinogenesis; 2014 Feb; 35(2):415-23. PubMed ID: 24072771
    [Abstract] [Full Text] [Related]

  • 3. (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma.
    Nihal M, Ahsan H, Siddiqui IA, Mukhtar H, Ahmad N, Wood GS.
    Cell Cycle; 2009 Jul 01; 8(13):2057-63. PubMed ID: 19502799
    [Abstract] [Full Text] [Related]

  • 4. Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
    Chamcheu JC, Siddiqui IA, Adhami VM, Esnault S, Bharali DJ, Babatunde AS, Adame S, Massey RJ, Wood GS, Longley BJ, Mousa SA, Mukhtar H.
    Int J Nanomedicine; 2018 Jul 01; 13():4189-4206. PubMed ID: 30057446
    [Abstract] [Full Text] [Related]

  • 5. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
    Nihal M, Ahmad N, Mukhtar H, Wood GS.
    Int J Cancer; 2005 Apr 20; 114(4):513-21. PubMed ID: 15609335
    [Abstract] [Full Text] [Related]

  • 6. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.
    Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995
    [Abstract] [Full Text] [Related]

  • 7. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
    Singh M, Bhatnagar P, Mishra S, Kumar P, Shukla Y, Gupta KC.
    Int J Nanomedicine; 2015 Jan 08; 10():6789-809. PubMed ID: 26586942
    [Abstract] [Full Text] [Related]

  • 8. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.
    Siddiqui IA, Adhami VM, Bharali DJ, Hafeez BB, Asim M, Khwaja SI, Ahmad N, Cui H, Mousa SA, Mukhtar H.
    Cancer Res; 2009 Mar 01; 69(5):1712-6. PubMed ID: 19223530
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G, Venè R, Morini M, Minghelli S, Benelli R, Noonan DM, Albini A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4865-73. PubMed ID: 15269163
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of green tea polyphenol EGCG((-)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway.
    Yang C, Du W, Yang D.
    Int J Food Sci Nutr; 2016 Nov 15; 67(7):818-27. PubMed ID: 27338284
    [Abstract] [Full Text] [Related]

  • 11. Nanochemoprevention: sustained release of bioactive food components for cancer prevention.
    Siddiqui IA, Adhami VM, Ahmad N, Mukhtar H.
    Nutr Cancer; 2010 Nov 15; 62(7):883-90. PubMed ID: 20924964
    [Abstract] [Full Text] [Related]

  • 12. Nanochemoprevention by bioactive food components: a perspective.
    Siddiqui IA, Mukhtar H.
    Pharm Res; 2010 Jun 15; 27(6):1054-60. PubMed ID: 20221894
    [Abstract] [Full Text] [Related]

  • 13. Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion.
    Ellis LZ, Liu W, Luo Y, Okamoto M, Qu D, Dunn JH, Fujita M.
    Biochem Biophys Res Commun; 2011 Oct 28; 414(3):551-6. PubMed ID: 21982776
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer.
    Man GCW, Wang J, Song Y, Wong JH, Zhao Y, Lau TS, Leung KT, Chan TH, Wang H, Kwong J, Ng TB, Wang CC.
    BMC Cancer; 2020 Oct 06; 20(1):964. PubMed ID: 33023525
    [Abstract] [Full Text] [Related]

  • 15. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B, Ying H, Yu C, Fan Z, Zhang W, Shi J, Ying H, Ravichandran N, Xu Y, Yin J, Jiang Y, Du Q.
    Int J Pharm; 2016 Oct 15; 512(1):22-31. PubMed ID: 27544847
    [Abstract] [Full Text] [Related]

  • 16. The therapeutic potential of epigallocatechin‑3‑gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study.
    Yoshimura H, Yoshida H, Matsuda S, Ryoke T, Ohta K, Ohmori M, Yamamoto S, Kiyoshima T, Kobayashi M, Sano K.
    Mol Med Rep; 2019 Aug 15; 20(2):1139-1148. PubMed ID: 31173211
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs.
    Yang H, Sun DK, Chen D, Cui QC, Gu YY, Jiang T, Chen W, Wan SB, Dou QP.
    Cancer Lett; 2010 Jun 01; 292(1):48-53. PubMed ID: 19962231
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
    Zhang L, Chen W, Tu G, Chen X, Lu Y, Wu L, Zheng D.
    Int J Nanomedicine; 2020 Jun 01; 15():4417-4429. PubMed ID: 32606686
    [Abstract] [Full Text] [Related]

  • 20. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.
    Sanna V, Singh CK, Jashari R, Adhami VM, Chamcheu JC, Rady I, Sechi M, Mukhtar H, Siddiqui IA.
    Sci Rep; 2017 Feb 01; 7():41573. PubMed ID: 28145499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.